Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Lipoarabinomannan in Urine, Evaluation of the STANDARDTM F TB LAM FIA and Its Impact on the Initial Diagnosis of TB

NCT06306430 is registered in ClinicalTrials.gov with Ospedale San Raffaele as lead sponsor.

NCT NCT06306430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06306430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Lipoarabinomannan in Urine, Evaluation of the STANDARDTM F TB LAM FIA and Its Impact on the Initial Diagnosis of TB
Lead sponsor
Ospedale San Raffaele
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2024
Completion date
October 31, 2025
Enrollment
550 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diagnoses disease, tuberculosis